Get the Stockscreener App
73.47
1.67%
1.21
Corcept Therapeutics Inc stock is traded at $73.47, with a volume of 686.74K.
It is up +1.67% in the last 24 hours and down -11.60% over the past month.
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
See More
Previous Close:
$72.26
Open:
$72.97
24h Volume:
686.74K
Relative Volume:
0.80
Market Cap:
$7.74B
Revenue:
$628.56M
Net Income/Loss:
$141.82M
P/E Ratio:
58.31
EPS:
1.26
Net Cash Flow:
$142.60M
1W Performance:
+1.31%
1M Performance:
-11.60%
6M Performance:
+2.21%
1Y Performance:
+50.03%
1-Day Range:
$72.47
$74.22
1-Week Range:
$70.89
$74.77
52-Week Range:
$46.38
$117.33
Corcept Therapeutics Inc Stock (CORT) Company Profile
Name
Corcept Therapeutics Inc
Sector
Industry
Phone
650.688.8803
Address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Compare CORT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CORT
Corcept Therapeutics Inc
|
73.47 | 7.61B | 628.56M | 141.82M | 142.60M | 1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | -52.09M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-06-23 | Upgrade | Truist | Hold → Buy |
| Apr-11-23 | Initiated | SVB Securities | Market Perform |
| Apr-04-23 | Initiated | Piper Sandler | Overweight |
| Feb-15-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-01-22 | Downgrade | Truist | Buy → Hold |
| Jul-27-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-27-22 | Resumed | Canaccord Genuity | Buy |
| Feb-02-22 | Initiated | Canaccord Genuity | Buy |
| Jan-28-22 | Initiated | Truist | Buy |
| Aug-05-20 | Downgrade | Jefferies | Buy → Hold |
| Sep-24-19 | Initiated | Jefferies | Buy |
| Sep-06-19 | Initiated | H.C. Wainwright | Buy |
| Feb-04-19 | Downgrade | B. Riley FBR | Buy → Neutral |
| Aug-10-18 | Reiterated | Stifel | Hold |
| May-31-18 | Downgrade | Stifel | Buy → Hold |
| Mar-09-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Aug-31-17 | Initiated | Stifel | Buy |
| Feb-02-17 | Initiated | Ladenburg Thalmann | Buy |
| Apr-21-15 | Initiated | FBR Capital | Outperform |
| Jan-13-14 | Downgrade | Stifel | Buy → Hold |
| Aug-09-13 | Downgrade | Janney | Buy → Neutral |
| Aug-09-13 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Feb-21-12 | Reiterated | JMP Securities | Mkt Outperform |
| Jan-06-10 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Jul-17-08 | Initiated | Rodman & Renshaw | Mkt Outperform |
| Jun-21-07 | Upgrade | Punk, Ziegel & Co | Mkt Perform → Accumulate |
View All
Corcept Therapeutics Inc Stock (CORT) Latest News
Y Intercept Hong Kong Ltd Purchases 11,881 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Does Corcept Therapeutics Incorporated qualify in momentum factor screeningJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - newser.com
What hedge fund moves indicate for Corcept Therapeutics Incorporated (HTD) stock - newser.com
Is Corcept Therapeutics Incorporated (HTD) stock a top pick for value investorsPortfolio Return Report & Consistent Income Trade Ideas - newser.com
How hedge fund analytics apply to Corcept Therapeutics Incorporated stockGold Moves & Fast Entry Momentum Trade Alerts - newser.com
Will Corcept Therapeutics Incorporated (HTD) stock enhance shareholder valuePrice Action & AI Forecasted Entry/Exit Points - newser.com
Is Corcept Therapeutics Incorporated stock positioned well for digital economyMarket Performance Summary & Daily Entry Point Alerts - newser.com
Using Bollinger Bands to evaluate Corcept Therapeutics IncorporatedJobs Report & Daily Entry Point Trade Alerts - newser.com
Corcept Therapeutics Inc expected to post earnings of 14 cents a shareEarnings Preview - TradingView
Is Corcept Therapeutics Incorporated stock affected by interest rate hikesTrade Risk Assessment & Low Risk High Reward Ideas - newser.com
Emerald Mutual Fund Advisers Trust Acquires 113,088 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
How Corcept Therapeutics Incorporated stock compares to growth peersQuarterly Profit Report & Long-Term Investment Growth Plans - newser.com
Will Corcept Therapeutics Incorporated stock recover faster than market2025 Short Interest & Fast Gaining Stock Reports - newser.com
Does Corcept Therapeutics Incorporated (HTD) stock trade below intrinsic valueMarket Activity Summary & Technical Entry and Exit Alerts - newser.com
How reliable is Corcept Therapeutics Incorporated (HTD) stock dividend growthMarket Risk Report & Fast Moving Stock Watchlists - newser.com
What momentum indicators show for Corcept Therapeutics Incorporated stock2025 Top Gainers & Reliable Volume Spike Trade Alerts - newser.com
What Corcept Therapeutics (CORT)'s Phase 3 Relacorilant Data Means for Shareholders - Yahoo Finance
Using data models to predict Corcept Therapeutics Incorporated stock movementPortfolio Profit Report & Long-Term Growth Plans - newser.com
Emerald Advisers LLC Purchases 179,871 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Risk vs reward if holding onto Corcept Therapeutics IncorporatedPortfolio Value Report & Accurate Trade Setup Notifications - newser.com
Identifying reversal signals in Corcept Therapeutics IncorporatedJuly 2025 Movers & Real-Time Volume Analysis Alerts - newser.com
Will Corcept Therapeutics Incorporated (HTD) stock extend growth storyRate Hike & Fast Exit Strategy with Risk Control - newser.com
Detecting support and resistance levels for Corcept Therapeutics IncorporatedAnalyst Upgrade & Community Supported Trade Ideas - newser.com
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call - BioSpace
Is Corcept Therapeutics Incorporated stock dividend yield sustainableProfit Target & Safe Capital Allocation Plans - fcp.pa.gov.br
Why analysts upgrade Corcept Therapeutics Incorporated stockQuarterly Risk Review & Daily Oversold Stock Bounce Ideas - fcp.pa.gov.br
Key metrics from Corcept Therapeutics Incorporated’s quarterly dataJuly 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com
Is Corcept Therapeutics Incorporated (HTD) stock attractive for growth fundsQuarterly Trade Report & Community Verified Swing Trade Signals - newser.com
Is Corcept Therapeutics Incorporated stock a buy before product launchesBreakout Watch & Verified Momentum Watchlists - Fundação Cultural do Pará
Corcept Therapeutics Incorporated (NASDAQ:CORT) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
What indicators show strength in Corcept Therapeutics IncorporatedAnalyst Downgrade & High Yield Stock Recommendations - newser.com
Corcept Therapeutics Inc Stock (CORT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):